Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Genetic Lingo

Genetic Lingo

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacogenomics and its importance in pediatric medicine.

Journal of pediatric genetics·2016

Same author

Pharmacogenomics and pharmacoepigenomics in pediatric medicine.

Methods in molecular biology (Clifton, N.J.)·2014

Same author

Endothelial nitric oxide synthase gene promoter polymorphism (T-786C) may be associated with advanced retinopathy of prematurity.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2012

Same author

Retinal ganglion cell (RGC) death in glaucomatous beagles is not associated with mutations in p53 and NTF4 genes.

Veterinary ophthalmology·2012

Same author

Lack of association of VEGF gene 3'- UTR polymorphisms (C702T, C936T and G1612A) and the risk of developing advanced retinopathy of prematurity (ROP).

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2012

Same author

Pharmacogenomics in ophthalmology.

Discovery medicine·2011

Search research articles

Related Experiment Video

Updated: May 14, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Genetic susceptibility to primary angle closure glaucoma (PACG).

Barkur S Shastry¹

¹Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA. shastry@oakland.edu

Discovery Medicine

|February 5, 2013

Summary

Primary angle-closure glaucoma (PACG) is a complex eye disease with a poorly understood genetic basis. Future research using animal models may help identify genes contributing to PACG.

Area of Science:

Ophthalmology
Genetics
Public Health

Background:

Primary angle-closure glaucoma (PACG) is a leading cause of irreversible blindness globally.
PACG is characterized by iridocorneal angle closure due to anatomical abnormalities, with higher prevalence in specific ethnic groups.
Genetic factors are suspected in PACG pathogenesis due to familial clustering, but the exact genetic basis remains unclear.

Purpose of the Study:

To review the current understanding of genetic investigations in primary angle-closure glaucoma.
To highlight the complexity and challenges in identifying causative genes for PACG.
To explore the potential of animal models in future genetic research for PACG.

Main Methods:

Review of existing literature on genetic studies related to PACG.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Related Experiment Videos

Last Updated: May 14, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Summary of findings from genome-wide association studies (GWAS) in various populations.

Discussion of limitations and controversies in current genetic research for PACG.

Main Results:

Genome-wide association studies have identified candidate genes for PACG, but results lack consistency across populations.
The genetic architecture of PACG is complex, likely involving multiple genes and environmental interactions.
Current genetic findings for PACG are often controversial and not widely reproducible.

Conclusions:

The genetic basis of PACG is intricate and not fully elucidated.
Further research, potentially utilizing large animal models, is needed to identify genes involved in PACG pathophysiology.
Understanding the genetic factors of PACG is crucial for developing effective prevention and treatment strategies.